KRAS gene | sciencenewsnet.in

Breaking News

Beyond Higher Temperatures: Preparing for National Security Risks Posed by Climate Change

Extracting High-Purity Gold from Electrical and Electronic Waste

Innovation Tri-Valley Leadership Group and the Hertz Foundation Announce Partnership to Celebrate World-Class Talent

AANA Presents Excellence in State Government Relations Advocacy Award to Georgia

Being treated by a female physician associated with lower risk for death

Firearm violence risk score may help tailor, disseminate prevention efforts in emergency departments

ACP recommends an evidence-based public health approach to excessive alcohol use

System-level factors influence doctors to reduce low-value care practices

Treatment from female doctors leads to lower mortality and hospital readmission rates

Historical redlining associated with higher rate of firearm fatalities

23 Apr, 2024

Mount Sinai Awarded Three-Year Grant to Explore Therapeutic Approaches to KRAS Mutant Lung Tumors

August 9, 2022 sarah JonasAnnouncement

Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.